Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessReview

Heparin-induced thrombocytopenia: an update

Massimo Franchini email

Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera di Verona, Verona, Italy

author email corresponding author email

Thrombosis Journal 2005, 3:14doi:10.1186/1477-9560-3-14

Published: 4 October 2005

Abstract

Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized. In this review, we briefly discuss the main features of heparin-induced thrombocytopenia, particularly analyzing the most recent advances in the pathophysiology, diagnosis and treatment of this syndrome.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.